Trehalose induced antidepressant-like effects and autophagy enhancement in mice

[1]  L. Leocani,et al.  Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of Tuberous Sclerosis Complex , 2013, Neuropharmacology.

[2]  R. Duman,et al.  mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade. , 2012, The international journal of neuropsychopharmacology.

[3]  A. Haqqani,et al.  Cerebral Ischemia Induced Proteomic Alterations: Consequences for the Synapse and Organelles , 2012 .

[4]  M. Balestrino.  Advances in the Preclinical Study of Ischemic Stroke , 2012 .

[5]  Lea M. Harder,et al.  Supplemental material Identification of autophagosome-associated proteins and regulators by quantitative proteomic analysis and genetic screens , 2012 .

[6]  G. Anderson,et al.  Modeling mania: Further validation for Black Swiss mice as model animals , 2011, Behavioural Brain Research.

[7]  M. Kalinichev,et al.  Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania. , 2011, The international journal of neuropsychopharmacology.

[8]  E. Kavalali,et al.  NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses , 2011, Nature.

[9]  F. Holsboer,et al.  Antidepressant Drugs Diversely Affect Autophagy Pathways in Astrocytes and Neurons—Dissociation from Cholesterol Homeostasis , 2011, Neuropsychopharmacology.

[10]  S. Cloonan,et al.  The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug‐resistant Burkitt's lymphoma , 2011, International journal of cancer.

[11]  Yifa Zhou,et al.  Antidepressant-like effects of the active acidic polysaccharide portion of ginseng in mice. , 2010, Journal of ethnopharmacology.

[12]  A. Cuervo,et al.  Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation , 2010, Neurobiology of Disease.

[13]  J. Cryan,et al.  A Glutamate Pathway to Faster-Acting Antidepressants? , 2010, Science.

[14]  Nanxin Li,et al.  mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists , 2010, Science.

[15]  H. Einat,et al.  Strain-Specific Battery of Tests for Domains of Mania: Effects of Valproate, Lithium and Imipramine , 2010, Front. Psychiatry.

[16]  G. Addolorato,et al.  New Advances in Addiction Medicine , 2010, Front. Psychiatry.

[17]  S. Tugtekin,et al.  Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement. , 2009, Transplantation proceedings.

[18]  M. Riva,et al.  Neuronal plasticity: A link between stress and mood disorders , 2009, Psychoneuroendocrinology.

[19]  D. Klionsky,et al.  Regulation mechanisms and signaling pathways of autophagy. , 2009, Annual review of genetics.

[20]  G. Cagney,et al.  Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression , 2009, Molecular Psychiatry.

[21]  H. Einat,et al.  A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior. , 2009, Journal of pharmacological and toxicological methods.

[22]  H. Schätzl,et al.  Autophagy induction by trehalose counter-acts cellular prion-infection , 2009, Autophagy.

[23]  H. Einat,et al.  Attenuation of high sweet solution preference by mood stabilizers: A possible mouse model for the increased reward-seeking domain of mania , 2009, Journal of Neuroscience Methods.

[24]  Chia-Ron Yang,et al.  Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease , 2009, Journal of neuroscience research.

[25]  M. Popoli,et al.  Cellular and molecular mechanisms in the long-term action of antidepressants. , 2008, Dialogues in clinical neuroscience.

[26]  J. Linde,et al.  Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders , 2008, Brain Research Bulletin.

[27]  C. Korth,et al.  Insolubility of Disrupted-in-Schizophrenia 1 Disrupts Oligomer-Dependent Interactions with Nuclear Distribution Element 1 and Is Associated with Sporadic Mental Disease , 2008, The Journal of Neuroscience.

[28]  John L Cleveland,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes , 2008, Autophagy.

[29]  G. Réus,et al.  Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[30]  H. Manji,et al.  β-Catenin Overexpression in the Mouse Brain Phenocopies Lithium-Sensitive Behaviors , 2007, Neuropsychopharmacology.

[31]  H. Manji,et al.  Strain Differences in Lithium Attenuation of d-Amphetamine-Induced Hyperlocomotion: A Mouse Model for the Genetics of Clinical Response to Lithium , 2007, Neuropsychopharmacology.

[32]  S. Schreiber,et al.  Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. , 2007, Nature chemical biology.

[33]  H. Manji,et al.  Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders. , 2006, Current drug targets.

[34]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[35]  H. Manji,et al.  Cellular Plasticity Cascades: Genes-To-Behavior Pathways in Animal Models of Bipolar Disorder , 2006, Biological Psychiatry.

[36]  Kyla Pennington,et al.  Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease‐associated changes , 2006, Proteomics.

[37]  D. Rubinsztein,et al.  Inositol and IP3 Levels Regulate Autophagy—Biology and Therapeutic Speculations , 2006, Autophagy.

[38]  H. Manji,et al.  Mood stabilizers target cellular plasticity and resilience cascades , 2005, Molecular Neurobiology.

[39]  R. Belmaker,et al.  Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder. , 2005, Bipolar disorders.

[40]  G. Haddad,et al.  Role of trehalose phosphate synthase and trehalose during hypoxia: from flies to mammals , 2004, Journal of Experimental Biology.

[41]  Chan Beum Park,et al.  Inhibition of insulin amyloid formation by small stress molecules , 2004, FEBS letters.

[42]  J. Solich,et al.  The effect of combined treatment with imipramine and amantadine on the behavioral reactivity of central &agr;1-adrenergic system in rats , 2004, Behavioural pharmacology.

[43]  N. Nukina,et al.  Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease , 2004, Nature Medicine.

[44]  T. Svensson,et al.  Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes. , 2003, The international journal of neuropsychopharmacology.

[45]  G. R. Cannell,et al.  Inhibition of tubulin assembly and covalent binding to microtubular protein by valproic acid glucuronide in vitro. , 2002, Life sciences.

[46]  K. Fischbeck,et al.  Toxic Proteins in Neurodegenerative Disease , 2002, Science.

[47]  T. Higashiyama.  Novel functions and applications of trehalose , 2002 .

[48]  C. Altar,et al.  Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523 , 2001, Neuropharmacology.

[49]  D. Janowsky,et al.  Association between preference for sweets and excessive alcohol intake: a review of animal and human studies. , 1999, Alcohol and alcoholism.

[50]  S. Lindquist,et al.  Multiple effects of trehalose on protein folding in vitro and in vivo. , 1998, Molecular cell.

[51]  C. DiLullo,et al.  Rapid Degradation of Newly Synthesized Tubulin in Lithium‐Treated Sensory Neurons , 1991, Journal of neurochemistry.

[52]  P. Piazza,et al.  Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration , 1990, Brain Research.

[53]  R. Wise,et al.  Environment-specific cross-sensitization between the locomotor activating effects of morphine and amphetamine , 1989, Pharmacology Biochemistry and Behavior.

[54]  J. Fuentes,et al.  Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases. , 1989, European journal of pharmacology.

[55]  T. Robinson,et al.  Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis , 1986, Brain Research Reviews.

[56]  K. Wȩdzony,et al.  Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)‐amphetamine given into the nucleus accumbens , 1985, The Journal of pharmacy and pharmacology.

[57]  J. Maj.  Central effects following repeated treatment with antidepressant drugs. , 1984, Polish journal of pharmacology and pharmacy.

[58]  R. Porsolt,et al.  "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. , 1978, European journal of pharmacology.

[59]  R. Porsolt,et al.  Behavioural despair in rats: a new model sensitive to antidepressant treatments. , 1978, European journal of pharmacology.

[60]  P. Willner,et al.  Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant , 2004, Psychopharmacology.

[61]  B. Pitt.  Psychopharmacology , 1968, Mental Health.